The Confidentiality of Substance Use Disorder Patient Records regulations (42 CFR Part 2), aka “Part 2,” protect patient privacy when receiving substance use disorder treatment. The Substance Abuse and Mental Health Services Administration (SAMHSA) has proposed changes to these rules based on stakeholder feedback and to facilitate coordination of care. The proposals include allowing non-opioid treatment program providers to become eligible to get information from prescription drug monitoring programs and changing the requirements for patient consent. See this HHS Fact Sheet for a summary of the proposals and RHIhub for more information on substance use disorder treatment in rural areas. Comments are due on October 25, 2019.
